US3854480A
(en)
|
1969-04-01 |
1974-12-17 |
Alza Corp |
Drug-delivery system
|
US3906092A
(en)
|
1971-11-26 |
1975-09-16 |
Merck & Co Inc |
Stimulation of antibody response
|
US4469863A
(en)
|
1980-11-12 |
1984-09-04 |
Ts O Paul O P |
Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
|
US4675189A
(en)
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
US5023243A
(en)
|
1981-10-23 |
1991-06-11 |
Molecular Biosystems, Inc. |
Oligonucleotide therapeutic agent and method of making same
|
JP2547714B2
(ja)
|
1981-10-23 |
1996-10-23 |
モルキユラ− バイオシステムズ インコ−ポレテツド |
オリゴヌクレオチド治療剤及びその製法
|
ES8301593A1
(es)
|
1981-11-16 |
1983-01-01 |
Union Ind Y Agro Ganader S A U |
Procedimiento de obtencion de una leche humanizada adiciona-da de nucleotidos con destino a la alimentacion infantil.
|
US4452775A
(en)
|
1982-12-03 |
1984-06-05 |
Syntex (U.S.A.) Inc. |
Cholesterol matrix delivery system for sustained release of macromolecules
|
US4627850A
(en)
|
1983-11-02 |
1986-12-09 |
Alza Corporation |
Osmotic capsule
|
US5194428A
(en)
|
1986-05-23 |
1993-03-16 |
Worcester Foundation For Experimental Biology |
Inhibition of influenza virus replication by oligonucleotide phosphorothioates
|
US4806463A
(en)
|
1986-05-23 |
1989-02-21 |
Worcester Foundation For Experimental Biology |
Inhibition of HTLV-III by exogenous oligonucleotides
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
US5264423A
(en)
|
1987-03-25 |
1993-11-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibitors for replication of retroviruses and for the expression of oncogene products
|
US5276019A
(en)
|
1987-03-25 |
1994-01-04 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibitors for replication of retroviruses and for the expression of oncogene products
|
ES2007350A6
(es)
|
1987-05-29 |
1989-06-16 |
Ganadera Union Ind Agro |
Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
|
CA1339596C
(en)
|
1987-08-07 |
1997-12-23 |
New England Medical Center Hospitals, Inc. |
Viral expression inhibitors
|
US5004810A
(en)
|
1988-09-30 |
1991-04-02 |
Schering Corporation |
Antiviral oligomers
|
US6214804B1
(en)
|
1989-03-21 |
2001-04-10 |
Vical Incorporated |
Induction of a protective immune response in a mammal by injecting a DNA sequence
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
US5786189A
(en)
|
1989-11-29 |
1998-07-28 |
Smithkline Beecham Biologicals (S.A.) |
Vaccine
|
US5457189A
(en)
|
1989-12-04 |
1995-10-10 |
Isis Pharmaceuticals |
Antisense oligonucleotide inhibition of papillomavirus
|
US5514577A
(en)
|
1990-02-26 |
1996-05-07 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide therapies for modulating the effects of herpes viruses
|
US5248670A
(en)
|
1990-02-26 |
1993-09-28 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotides for inhibiting herpesviruses
|
US5166195A
(en)
|
1990-05-11 |
1992-11-24 |
Isis Pharmaceuticals, Inc. |
Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
|
EP0468520A3
(en)
|
1990-07-27 |
1992-07-01 |
Mitsui Toatsu Chemicals, Inc. |
Immunostimulatory remedies containing palindromic dna sequences
|
US6042838A
(en)
*
|
1991-02-15 |
2000-03-28 |
Uab Research Foundation |
immunogenic compositions for mucosal administration of pneumococcal surface protein A (PspA)
|
US5407686A
(en)
|
1991-11-27 |
1995-04-18 |
Sidmak Laboratories, Inc. |
Sustained release composition for oral administration of active ingredient
|
WO1993015207A2
(en)
|
1992-02-04 |
1993-08-05 |
Viagene, Inc. |
Hepatitis therapeutics
|
US6498147B2
(en)
|
1992-05-22 |
2002-12-24 |
The Scripps Research Institute |
Suppression of nuclear factor-κb dependent processes using oligonucleotides
|
US5585479A
(en)
|
1992-07-24 |
1996-12-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Antisense oligonucleotides directed against human ELAM-I RNA
|
WO1994008004A1
(en)
|
1992-10-05 |
1994-04-14 |
Hybridon, Inc. |
Therapeutic anti-hiv oligonucleotide and pharmaceutical
|
US5567604A
(en)
|
1993-04-23 |
1996-10-22 |
Aronex Pharmaceuticals, Inc. |
Anti-viral guanosine-rich oligonucleotides
|
JP2798305B2
(ja)
|
1993-06-23 |
1998-09-17 |
ジェネシス ファーマ インコーポレイテッド |
アンチセンスオリゴヌクレオチドおよびヒト免疫不全ウイルス感染におけるその使用
|
US20030109469A1
(en)
|
1993-08-26 |
2003-06-12 |
Carson Dennis A. |
Recombinant gene expression vectors and methods for use of same to enhance the immune response of a host to an antigen
|
US5985847A
(en)
|
1993-08-26 |
1999-11-16 |
The Regents Of The University Of California |
Devices for administration of naked polynucleotides which encode biologically active peptides
|
US5830877A
(en)
|
1993-08-26 |
1998-11-03 |
The Regents Of The University Of California |
Method, compositions and devices for administration of naked polynucleotides which encode antigens and immunostimulatory
|
US5849719A
(en)
|
1993-08-26 |
1998-12-15 |
The Regents Of The University Of California |
Method for treating allergic lung disease
|
US5804566A
(en)
|
1993-08-26 |
1998-09-08 |
The Regents Of The University Of California |
Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
|
US5679647A
(en)
|
1993-08-26 |
1997-10-21 |
The Regents Of The University Of California |
Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
|
US6133244A
(en)
*
|
1993-10-22 |
2000-10-17 |
Institut Pasteur |
Method for immunization against hepatitis B
|
AU710504B2
(en)
|
1994-03-15 |
1999-09-23 |
Brown University Research Foundation |
Polymeric gene delivery system
|
US6727230B1
(en)
*
|
1994-03-25 |
2004-04-27 |
Coley Pharmaceutical Group, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
WO1995026204A1
(en)
|
1994-03-25 |
1995-10-05 |
Isis Pharmaceuticals, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US20030050263A1
(en)
|
1994-07-15 |
2003-03-13 |
The University Of Iowa Research Foundation |
Methods and products for treating HIV infection
|
ATE420171T1
(de)
*
|
1994-07-15 |
2009-01-15 |
Univ Iowa Res Found |
Immunomodulatorische oligonukleotide
|
US20030026782A1
(en)
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
US7935675B1
(en)
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US5646262A
(en)
|
1994-07-28 |
1997-07-08 |
Georgetown University |
Antisense oligonucleotides against hepatitis B viral replication
|
US6630455B1
(en)
|
1995-01-13 |
2003-10-07 |
Vanderbilt University |
Methods for inducing mucosal immune responses
|
GB9503863D0
(en)
|
1995-02-25 |
1995-04-19 |
Smithkline Beecham Biolog |
Vaccine compositions
|
US5994315A
(en)
|
1995-06-07 |
1999-11-30 |
East Carolina University |
Low adenosine agent, composition, kit and method for treatment of airway disease
|
WO1997003702A1
(en)
|
1995-07-21 |
1997-02-06 |
Brown University Research Foundation |
A method for gene therapy using nucleic acid loaded polymeric microparticles
|
US6248720B1
(en)
|
1996-07-03 |
2001-06-19 |
Brown University Research Foundation |
Method for gene therapy using nucleic acid loaded polymeric microparticles
|
DE69637942D1
(de)
|
1995-10-04 |
2009-07-09 |
Immunex Corp |
Stimulationsfaktor für dendriten
|
US5736152A
(en)
|
1995-10-27 |
1998-04-07 |
Atrix Laboratories, Inc. |
Non-polymeric sustained release delivery system
|
US5780448A
(en)
|
1995-11-07 |
1998-07-14 |
Ottawa Civic Hospital Loeb Research |
DNA-based vaccination of fish
|
US5840332A
(en)
|
1996-01-18 |
1998-11-24 |
Perio Products Ltd. |
Gastrointestinal drug delivery system
|
EP1346649A3
(en)
|
1996-01-22 |
2003-12-10 |
Chr. Hansen A/S |
Water dispersible compositions containing natural hydrophobic pigment, method of preparing same and their use
|
EP0879284B1
(en)
|
1996-01-30 |
2009-07-29 |
The Regents of The University of California |
Gene expression vectors which generate an antigen specific immune response and methods of using the same
|
US20030078223A1
(en)
|
1996-01-30 |
2003-04-24 |
Eyal Raz |
Compositions and methods for modulating an immune response
|
US6689757B1
(en)
*
|
1996-02-12 |
2004-02-10 |
M.L. Laboratories Plc |
Methods for vaccination and vaccines therefor
|
SE9600647D0
(sv)
|
1996-02-21 |
1996-02-21 |
Bror Morein |
Ny användning
|
US6030955A
(en)
|
1996-03-21 |
2000-02-29 |
The Trustees Of Columbia University In The City Of New York And Imclone Systems, Inc. |
Methods of affecting intracellular phosphorylation of tyrosine using phosphorothioate oligonucleotides, and antiangiogenic and antiproliferative uses thereof
|
AU705647B2
(en)
|
1996-07-10 |
1999-05-27 |
Immunex Corporation |
Method of activating dendritic cells
|
ATE292980T1
(de)
*
|
1996-10-11 |
2005-04-15 |
Univ California |
Immunostimulierende oligonucleotidekonjugate
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
WO1998037919A1
(en)
|
1997-02-28 |
1998-09-03 |
University Of Iowa Research Foundation |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
DK1005368T3
(da)
|
1997-03-10 |
2010-01-04 |
Ottawa Hospital Res Inst |
Anvendelse af nukleinsyrer, der indeholder ikke-metyleret CpG dinukleotid i kombination med alun som hjælpestoffer
|
US6426334B1
(en)
*
|
1997-04-30 |
2002-07-30 |
Hybridon, Inc. |
Oligonucleotide mediated specific cytokine induction and reduction of tumor growth in a mammal
|
KR20010020370A
(ko)
|
1997-04-30 |
2001-03-15 |
파샬 비. 린네 |
향상된 생체이용률을 갖는 올리고뉴클레오티드
|
US6287591B1
(en)
|
1997-05-14 |
2001-09-11 |
Inex Pharmaceuticals Corp. |
Charged therapeutic agents encapsulated in lipid particles containing four lipid components
|
US20030104044A1
(en)
|
1997-05-14 |
2003-06-05 |
Semple Sean C. |
Compositions for stimulating cytokine secretion and inducing an immune response
|
CA2289741A1
(en)
*
|
1997-05-19 |
1998-11-26 |
Merck & Co., Inc. |
Oligonucleotide adjuvant
|
EP1003531B1
(en)
|
1997-05-20 |
2007-08-22 |
Ottawa Health Research Institute |
Processes for preparing nucleic acid constructs
|
US6589940B1
(en)
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
JP4101888B2
(ja)
|
1997-06-06 |
2008-06-18 |
ダイナバックス テクノロジーズ コーポレイション |
免疫刺激オリゴヌクレオチド、その組成物およびその使用方法
|
US20040006034A1
(en)
|
1998-06-05 |
2004-01-08 |
Eyal Raz |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
US6221882B1
(en)
|
1997-07-03 |
2001-04-24 |
University Of Iowa Research Foundation |
Methods for inhibiting immunostimulatory DNA associated responses
|
US5877309A
(en)
|
1997-08-13 |
1999-03-02 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotides against JNK
|
AU757175B2
(en)
|
1997-09-05 |
2003-02-06 |
Regents Of The University Of California, The |
Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
|
US6749856B1
(en)
*
|
1997-09-11 |
2004-06-15 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Mucosal cytotoxic T lymphocyte responses
|
WO1999030686A1
(en)
|
1997-12-12 |
1999-06-24 |
Inex Pharmaceuticals Corp. |
Cationic drugs encapsulated in anionic liposomes
|
GB9727262D0
(en)
|
1997-12-24 |
1998-02-25 |
Smithkline Beecham Biolog |
Vaccine
|
US20050031638A1
(en)
|
1997-12-24 |
2005-02-10 |
Smithkline Beecham Biologicals S.A. |
Vaccine
|
JPH11209289A
(ja)
|
1998-01-22 |
1999-08-03 |
Taisho Pharmaceut Co Ltd |
粘膜免疫誘起剤
|
AU760549B2
(en)
|
1998-04-03 |
2003-05-15 |
University Of Iowa Research Foundation, The |
Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
|
PL354714A1
(en)
|
1998-04-09 |
2004-02-09 |
Smithkline Beecham Biologicals S.A. |
Adjuvant compositions
|
EP1100834B1
(en)
|
1998-04-28 |
2006-06-28 |
Inex Pharmaceuticals Corp. |
Polyanionic polymers which enhance fusogenicity
|
CA2328602A1
(en)
|
1998-05-06 |
1999-11-11 |
University Of Iowa Research Foundation |
Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides
|
CA2328406A1
(en)
|
1998-05-14 |
1999-11-18 |
Hermann Wagner |
Methods for regulating hematopoiesis using cpg-oligonucleotides
|
DE69932717T2
(de)
|
1998-05-22 |
2007-08-09 |
Ottawa Health Research Institute, Ottawa |
Methoden und produkte zur induzierung mukosaler immunität
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
US6086898A
(en)
|
1998-06-23 |
2000-07-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of converting a Th2-type allergic immune response into a Th1-type immune response
|
US20040247662A1
(en)
|
1998-06-25 |
2004-12-09 |
Dow Steven W. |
Systemic immune activation method using nucleic acid-lipid complexes
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
US6693086B1
(en)
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
DE69906977T2
(de)
|
1998-07-20 |
2004-05-19 |
Protiva Biotherapeutics Inc., Burnaby |
In liposomen verkapselte nukleinsäurekomplexe
|
WO2000006588A1
(en)
|
1998-07-27 |
2000-02-10 |
University Of Iowa Research Foundation |
STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS
|
GB9817052D0
(en)
|
1998-08-05 |
1998-09-30 |
Smithkline Beecham Biolog |
Vaccine
|
US20010034330A1
(en)
|
1998-08-10 |
2001-10-25 |
Charlotte Kensil |
Innate immunity-stimulating compositions of CpG and saponin and methods thereof
|
DE69929444T2
(de)
|
1998-08-10 |
2006-09-28 |
Antigenics Inc., Woburn |
Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung
|
US6210663B1
(en)
|
1998-08-20 |
2001-04-03 |
The Wistar Institute Of Anatomy And Biology |
Methods of augmenting mucosal immunity through systemic priming and mucosal boosting
|
CA2341338A1
(en)
|
1998-09-03 |
2000-03-16 |
Coley Pharmaceutical Gmbh |
G-motif oligonucleotides and uses thereof
|
FR2783170B1
(fr)
|
1998-09-11 |
2004-07-16 |
Pasteur Merieux Serums Vacc |
Emulsion immunostimulante
|
EP1117433A1
(en)
|
1998-10-09 |
2001-07-25 |
Dynavax Technologies Corporation |
Anti hiv compositions comprising immunostimulatory polynucleotides and hiv antigens
|
DE69935606T9
(de)
|
1998-10-16 |
2021-03-11 |
Glaxosmithkline Biologicals S.A. |
Adjuvanzsysteme und impfstoffe
|
CZ20012544A3
(cs)
|
1999-01-12 |
2002-01-16 |
Smithkline Beecham Biologicals S.A. |
Farmaceutické balení
|
AU2977500A
(en)
|
1999-02-02 |
2000-08-25 |
Biocache Pharmaceuticals, Llc |
Advanced antigen presentation platform
|
JP2002536344A
(ja)
|
1999-02-05 |
2002-10-29 |
ジエンザイム コーポレイション |
抗腫瘍免疫を発生させるためのカチオン性脂質の使用
|
WO2000054803A2
(en)
|
1999-03-16 |
2000-09-21 |
Panacea Pharmaceuticals, Llc |
Immunostimulatory nucleic acids and antigens
|
CZ303653B6
(cs)
|
1999-03-19 |
2013-01-30 |
Smithkline Beecham Biologicals S. A. |
Imunogenní prostredek
|
FR2790955B1
(fr)
|
1999-03-19 |
2003-01-17 |
Assist Publ Hopitaux De Paris |
Utilisation d'oligonucleotides stabilises comme principe actif antitumoral
|
US6977245B2
(en)
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
EP1176966B1
(en)
|
1999-04-12 |
2013-04-03 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Oligodeoxynucleotide and its use to induce an immune response
|
AU4642600A
(en)
|
1999-04-15 |
2000-11-02 |
Regents Of The University Of California, The |
Methods and compositions for use in potentiating antigen presentation by antigenpresenting cells
|
WO2000062800A2
(en)
|
1999-04-19 |
2000-10-26 |
Smithkline Beecham Biologicals Sa |
Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
|
US6558670B1
(en)
|
1999-04-19 |
2003-05-06 |
Smithkline Beechman Biologicals S.A. |
Vaccine adjuvants
|
AU4978100A
(en)
|
1999-04-29 |
2000-11-17 |
Coley Pharmaceutical Gmbh |
Screening for immunostimulatory dna functional modifyers
|
US6737066B1
(en)
|
1999-05-06 |
2004-05-18 |
The Immune Response Corporation |
HIV immunogenic compositions and methods
|
OA11937A
(en)
|
1999-05-06 |
2006-04-12 |
Immune Response Corp Inc |
HIV immunogenic compositions and methods.
|
CA2376634A1
(en)
|
1999-06-08 |
2000-12-14 |
Aventis Pasteur |
Immunostimulant oligonucleotide
|
US6479504B1
(en)
|
1999-06-16 |
2002-11-12 |
The University Of Iowa Research Foundation |
Antagonism of immunostimulatory CpG-oligonucleotides by 4-aminoquinolines and other weak bases
|
ES2250151T3
(es)
|
1999-06-29 |
2006-04-16 |
Glaxosmithkline Biologicals S.A. |
Uso de cpg como adyuvante de vacuna contra vih.
|
GB9915204D0
(en)
|
1999-06-29 |
1999-09-01 |
Smithkline Beecham Biolog |
Vaccine
|
US6514948B1
(en)
|
1999-07-02 |
2003-02-04 |
The Regents Of The University Of California |
Method for enhancing an immune response
|
DE19935756A1
(de)
|
1999-07-27 |
2001-02-08 |
Mologen Forschungs Entwicklung |
Kovalent geschlossenes Nukleinsäuremolekül zur Immunstimulation
|
AU774380B2
(en)
|
1999-08-19 |
2004-06-24 |
Dynavax Technologies Corporation |
Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
|
US20050249794A1
(en)
|
1999-08-27 |
2005-11-10 |
Semple Sean C |
Compositions for stimulating cytokine secretion and inducing an immune response
|
GB9921146D0
(en)
|
1999-09-07 |
1999-11-10 |
Smithkline Beecham Biolog |
Novel composition
|
DE60022665T2
(de)
|
1999-09-25 |
2006-06-22 |
Coley Pharmaceutical Gmbh |
Immunstimulierende nukeinsäuren
|
US6949520B1
(en)
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
US7223398B1
(en)
|
1999-11-15 |
2007-05-29 |
Dynavax Technologies Corporation |
Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
|
AU2593701A
(en)
|
1999-12-21 |
2001-07-03 |
Regents Of The University Of California, The |
Method for preventing an anaphylactic reaction
|
EP1311288A1
(en)
|
2000-01-20 |
2003-05-21 |
Ottawa Health Research Institute |
Immunostimulatory nucleic acids for inducing a th2 immune response
|
US6852705B2
(en)
|
2000-01-21 |
2005-02-08 |
Merial |
DNA vaccines for farm animals, in particular bovines and porcines
|
PL211762B1
(pl)
|
2000-01-31 |
2012-06-29 |
Smithkline Beecham Biolog |
Zastosowanie białka fuzyjnego zawierającego białka HIV Tat i HIV Nef lub polinukleotyd kodujący takie białko, białka lub polinukleotydu HIV gp120, białka lub polinukleotydu SIV Nef, adiuwanta indukującego TH1 zawierającego monofosforylolipid A lub jego pochodną i adiuwanta saponinowego oraz kompozycja szczepionki
|
AU2001231245A1
(en)
|
2000-01-31 |
2001-08-07 |
The Regents Of The University Of California |
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen
|
US7585847B2
(en)
|
2000-02-03 |
2009-09-08 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for the treatment of asthma and allergy
|
FR2805265B1
(fr)
|
2000-02-18 |
2002-04-12 |
Aventis Pasteur |
Oligonucleotides immunostimulants
|
US20030130217A1
(en)
|
2000-02-23 |
2003-07-10 |
Eyal Raz |
Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
|
CA2399550A1
(en)
|
2000-02-23 |
2001-08-30 |
The Regents Of The University Of California |
Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
|
AU2001239873A1
(en)
|
2000-02-24 |
2001-09-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Adjuvant treatment by in vivo activation of dendritic cells
|
US20020156033A1
(en)
|
2000-03-03 |
2002-10-24 |
Bratzler Robert L. |
Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
|
US20040131628A1
(en)
|
2000-03-08 |
2004-07-08 |
Bratzler Robert L. |
Nucleic acids for the treatment of disorders associated with microorganisms
|
US20020028784A1
(en)
|
2000-03-10 |
2002-03-07 |
Nest Gary Van |
Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences
|
US7129222B2
(en)
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
US20020107212A1
(en)
|
2000-03-10 |
2002-08-08 |
Nest Gary Van |
Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences
|
US20020098199A1
(en)
|
2000-03-10 |
2002-07-25 |
Gary Van Nest |
Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
|
US20010046967A1
(en)
|
2000-03-10 |
2001-11-29 |
Gary Van Nest |
Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide
|
US7157437B2
(en)
|
2000-03-10 |
2007-01-02 |
Dynavax Technologies Corporation |
Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
WO2001072123A1
(en)
|
2000-03-28 |
2001-10-04 |
The Regents Of The University Of California |
Methods for increasing a cytotoxic t lymphocyte response in vivo
|
AU2001251407A1
(en)
|
2000-04-07 |
2001-10-23 |
The Regents Of The University Of California |
Synergistic improvements to polynucleotide vaccines
|
DE60139689D1
(de)
|
2000-06-22 |
2009-10-08 |
Univ Iowa Res Found |
Kombination von CpG und Antikörpern gegen CD19,CD20,CD22 oder CD40 zur Prävention oder Behandlung von Krebs.
|
US20020165178A1
(en)
|
2000-06-28 |
2002-11-07 |
Christian Schetter |
Immunostimulatory nucleic acids for the treatment of anemia, thrombocytopenia, and neutropenia
|
CN1549726A
(zh)
|
2000-07-31 |
2004-11-24 |
耶鲁大学 |
先天性免疫系统指导的疫苗
|
US20020198165A1
(en)
|
2000-08-01 |
2002-12-26 |
Bratzler Robert L. |
Nucleic acids for the prevention and treatment of gastric ulcers
|
US20020091097A1
(en)
|
2000-09-07 |
2002-07-11 |
Bratzler Robert L. |
Nucleic acids for the prevention and treatment of sexually transmitted diseases
|
WO2002022809A2
(en)
|
2000-09-15 |
2002-03-21 |
Coley Pharmaceutical Gmbh |
PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
|
GB0023008D0
(en)
|
2000-09-20 |
2000-11-01 |
Glaxo Group Ltd |
Improvements in vaccination
|
FR2814958B1
(fr)
*
|
2000-10-06 |
2003-03-07 |
Aventis Pasteur |
Composition vaccinale
|
EP2266603B1
(en)
|
2000-10-18 |
2012-09-12 |
GlaxoSmithKline Biologicals S.A. |
Tumour vaccines
|
AU2002214868A1
(en)
|
2000-11-02 |
2002-05-15 |
Inex Pharmaceuticals Corporation |
Therapeutic oligonucleotides of reduced toxicity
|
EP1985702A3
(en)
|
2000-12-08 |
2010-08-18 |
Coley Pharmaceutical GmbH |
CPG-like nucleic acids and methods of use thereof
|
WO2002053141A2
(en)
|
2000-12-14 |
2002-07-11 |
Coley Pharmaceutical Group, Inc. |
Inhibition of angiogenesis by nucleic acids
|
CA2430691A1
(en)
|
2000-12-27 |
2002-07-04 |
Dynavax Technologies Corporation |
Immunomodulatory polynucleotides and methods of using the same
|
AU2002248646A1
(en)
|
2001-03-16 |
2002-10-03 |
The Regents Of The University Of California |
Compositions and methods for modulating an immune response
|
US20030050268A1
(en)
|
2001-03-29 |
2003-03-13 |
Krieg Arthur M. |
Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases
|
JP2005509591A
(ja)
|
2001-06-15 |
2005-04-14 |
リバファーム・インコーポレイテッド |
ヌクレオシドワクチンアジュバント
|
US20030148316A1
(en)
|
2001-08-01 |
2003-08-07 |
Lipford Grayson B. |
Methods and compositions relating to plasmacytoid dendritic cells
|
AU2002326561B2
(en)
|
2001-08-07 |
2008-04-03 |
Dynavax Technologies Corporation |
Immunomodulatory compositions, formulations, and methods for use thereof
|
PT1446162E
(pt)
|
2001-08-17 |
2009-01-27 |
Coley Pharm Gmbh |
Agrupamentos imunoestimuladores oligonucléotidos com actividade melhorada
|
JP2005501550A
(ja)
|
2001-08-30 |
2005-01-20 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫反応調整剤分子を用いた形質細胞様樹状細胞を成熟させる方法
|
US20030119774A1
(en)
|
2001-09-25 |
2003-06-26 |
Marianna Foldvari |
Compositions and methods for stimulating an immune response
|
CA2461315A1
(en)
|
2001-10-05 |
2003-04-17 |
Coley Pharmaceutical Gmbh |
Toll-like receptor 3 signaling agonists and antagonists
|
AU2002347062B2
(en)
|
2001-10-06 |
2008-06-26 |
Merial Ltd |
CpG formulations and related methods
|
WO2003094836A2
(en)
|
2001-10-12 |
2003-11-20 |
University Of Iowa Research Foundation |
Methods and products for enhancing immune responses using imidazoquinoline compounds
|
AU2002340662B2
(en)
|
2001-11-07 |
2008-07-03 |
Tekmira Pharmaceuticals Corporation |
Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
|
TW200303759A
(en)
|
2001-11-27 |
2003-09-16 |
Schering Corp |
Methods for treating cancer
|
US8088388B2
(en)
|
2002-02-14 |
2012-01-03 |
United Biomedical, Inc. |
Stabilized synthetic immunogen delivery system
|
US20030232443A1
(en)
|
2002-06-18 |
2003-12-18 |
Isis Pharmaceuticals Inc. |
Antisense modulation of centromere protein B expression
|
CA2480775C
(en)
|
2002-04-04 |
2016-05-31 |
Coley Pharmaceutical Gmbh |
Immunostimulatory g,u-containing oligoribonucleotides
|
ATE411815T1
(de)
|
2002-05-10 |
2008-11-15 |
Tekmira Pharmaceuticals Corp |
Methylierte immunstimulierende oligodeoxynukleotide und verfahren zu deren verwendung
|
CA2487452A1
(en)
|
2002-05-28 |
2003-12-04 |
Robinson Ramirez-Pineda |
A method for generating antigen-presenting cells
|
AU2003243409A1
(en)
|
2002-06-05 |
2003-12-22 |
Coley Pharmaceutical Group, Inc. |
Method for treating autoimmune or inflammatory diseases with combinations of inhibitory oligonucleotides and small molecule antagonists of immunostimulatory cpg nucleic acids
|
US20040013688A1
(en)
|
2002-07-03 |
2004-01-22 |
Cambridge Scientific, Inc. |
Vaccines to induce mucosal immunity
|
US7569553B2
(en)
|
2002-07-03 |
2009-08-04 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7605138B2
(en)
|
2002-07-03 |
2009-10-20 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7576066B2
(en)
|
2002-07-03 |
2009-08-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7807803B2
(en)
|
2002-07-03 |
2010-10-05 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US20040053880A1
(en)
|
2002-07-03 |
2004-03-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
WO2004007743A2
(en)
|
2002-07-17 |
2004-01-22 |
Coley Pharmaceutical Gmbh |
Use of cpg nucleic acids in prion-disease
|
CN1468957A
(zh)
|
2002-07-19 |
2004-01-21 |
中国人民解放军第二军医大学 |
一种用作人用治疗性疫苗佐剂的质粒
|
AR040996A1
(es)
|
2002-08-19 |
2005-04-27 |
Coley Pharm Group Inc |
Acidos nucleicos inmunoestimuladores
|
WO2004026888A2
(en)
|
2002-09-19 |
2004-04-01 |
Coley Pharmaceutical Gmbh |
Toll-like receptor 9 (tlr9) from various mammalian species
|
EP1556077A2
(en)
|
2002-10-29 |
2005-07-27 |
Coley Pharmaceutical Group, Ltd |
Use of cpg oligonucleotides in the treatment of hepatitis c virus infection
|
AU2003300919A1
(en)
|
2002-12-11 |
2004-06-30 |
Coley Pharmaceutical Gmbh |
5' cpg nucleic acids and methods of use
|
KR100525321B1
(ko)
|
2002-12-13 |
2005-11-02 |
안웅식 |
파필로마바이러스 항원 단백질 및CpG-올리고데옥시뉴클레오타이드를 포함하는파필로마바이러스 유발 질환의 예방 또는 치료용 약제학적조성물
|
US20040235770A1
(en)
|
2003-04-02 |
2004-11-25 |
Coley Pharmaceutical Group, Ltd. |
Immunostimulatory nucleic acid oil-in-water formulations and related methods of use
|
EP1631687A2
(en)
|
2003-04-22 |
2006-03-08 |
Coley Pharmaceutical GmbH |
Methods and products for identification and assessment of tlr ligands
|
BRPI0411514A
(pt)
|
2003-06-20 |
2006-08-01 |
Coley Pharm Gmbh |
antagonistas de receptor toll-like de molécula pequena
|
CA2536139A1
(en)
|
2003-09-25 |
2005-04-07 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid-lipophilic conjugates
|
US20050215501A1
(en)
|
2003-10-24 |
2005-09-29 |
Coley Pharmaceutical Group, Inc. |
Methods and products for enhancing epitope spreading
|
SG122973A1
(en)
|
2003-10-30 |
2006-06-29 |
Coley Pharm Gmbh |
C-class oligonucleotide analogs with enhanced immunostimulatory potency
|
US20050239733A1
(en)
|
2003-10-31 |
2005-10-27 |
Coley Pharmaceutical Gmbh |
Sequence requirements for inhibitory oligonucleotides
|
US20050100983A1
(en)
|
2003-11-06 |
2005-05-12 |
Coley Pharmaceutical Gmbh |
Cell-free methods for identifying compounds that affect toll-like receptor 9 (TLR9) signaling
|
EP2415481A3
(en)
|
2004-02-19 |
2012-04-18 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory viral RNA oligonucleotides
|
WO2005111057A2
(en)
|
2004-04-02 |
2005-11-24 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for inducing il-10 responses
|
CA2567789A1
(en)
|
2004-06-08 |
2006-08-03 |
Coley Pharmaceutical Gmbh |
Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist
|
EP1776105A2
(en)
|
2004-07-18 |
2007-04-25 |
Coley Pharmaceutical Group, Ltd |
Methods and compositions for inducing innate immune responses
|
EP1781325A2
(en)
|
2004-07-18 |
2007-05-09 |
CSL Limited |
Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses
|
MY159370A
(en)
|
2004-10-20 |
2016-12-30 |
Coley Pharm Group Inc |
Semi-soft-class immunostimulatory oligonucleotides
|
AU2006216493A1
(en)
|
2005-02-24 |
2006-08-31 |
Coley Pharmaceutical Gmbh |
Immunostimulatory oligonucleotides
|
RS20070422A
(en)
|
2005-04-08 |
2009-01-22 |
Sanofi-Aventis U.S. Llc., |
Methods for treating infectious disease exacerbated asthma
|
WO2006116458A2
(en)
|
2005-04-26 |
2006-11-02 |
Coley Pharmaceutical Gmbh |
Modified oligoribonucleotide analogs with enhances immunostimulatory activity
|
JP2009508842A
(ja)
|
2005-09-16 |
2009-03-05 |
コーリー ファーマシューティカル ゲーエムベーハー |
ヌクレオチド修飾による短鎖干渉リボ核酸(siRNA)の免疫賦活性の調節
|
EP1928500A2
(en)
|
2005-09-27 |
2008-06-11 |
Coley Pharmaceutical GmbH |
Modulation of tlr-mediated immune responses using adaptor oligonucleotides
|
CA2630738C
(en)
|
2005-11-25 |
2013-09-03 |
Coley Pharmaceutical Gmbh |
Immunostimulatory oligoribonucleotides
|
JP5473336B2
(ja)
|
2006-02-15 |
2014-04-16 |
アディウタイド・ファーマスーティカルズ・ゲーエムベーハー |
オリゴヌクレオチドの処方に関する組成物および方法
|
US8027888B2
(en)
|
2006-08-31 |
2011-09-27 |
Experian Interactive Innovation Center, Llc |
Online credit card prescreen systems and methods
|
WO2008033432A2
(en)
|
2006-09-12 |
2008-03-20 |
Coley Pharmaceutical Group, Inc. |
Immune modulation by chemically modified ribonucleosides and oligoribonucleotides
|
NZ575437A
(en)
|
2006-09-27 |
2012-02-24 |
Coley Pharm Gmbh |
Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity
|
EP2068912A2
(en)
|
2006-09-27 |
2009-06-17 |
Coley Pharmaceutical Group, Inc. |
Compositions of tlr ligands and antivirals
|
BRPI0718182A2
(pt)
|
2006-10-26 |
2014-02-25 |
Coley Pharm Gmbh |
Oligorribonucleotídeos e seus usos.
|